LALINDEN ADVISORS LP

Institutional investor · Portfolio as of Q1 2019

SEC EDGAR SourceSEC Filings

Top Holdings134 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
205.8M$337.1M7.7%
1 qtr
New
96
291.4M$321.3M7.4%
1 qtr
New
96
AABAAABADelisted
Fund

ALTABA INC

3.8M$278.7M6.4%
1 qtr
New
95
??TELADOC HEALTH INCDelisted
Bond
138.4M$206M4.7%
New
85
??HUAZHU GROUP LTDDelisted
Bond
158.3M$182M4.2%
1 qtr
New
84
155.4M$151.7M3.5%
1 qtr
New
84
73.6M$133M3.0%
1 qtr
New
84
??EVERBRIDGE INCDelisted
Bond
57.8M$130.9M3.0%
New
78
??RINGCENTRAL INCDelisted
Bond
84.8M$120.8M2.8%
New
78
??OKTA INCDelisted
Bond
64.5M$117M2.7%
New
78
??Wayfair IncDelisted
Bond
56.6M$86.8M2.0%
New
68
??EXACT SCIENCES CORPDelisted
Bond
60.9M$83.3M1.9%
1 qtr
New
68
80.8M$82M1.9%
New
68
??INNOVIVA INCDelisted
Bond
74.9M$80.3M1.8%
1 qtr
New
68
??COLONY CAP INCDelisted
Bond
81.4M$78.4M1.8%
1 qtr
New
68
75.1M$73.8M1.7%
1 qtr
New
68
64.3M$65.5M1.5%
New
67
63.9M$64.9M1.5%
1 qtr
New
67
36.5M$64.2M1.5%
New
67
62.7M$61.1M1.4%
1 qtr
New
67
$4.4B
AUM
134
Positions
Q1 2019
Filing
Rating · 2.0
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q1'19
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity99%Puts0%Calls1%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

LINDEN ADVISORS LP manages $4.4B across 134 positions as of Q1 2019. Top holdings: MICROCHIP TECHNOLOGY INC. (7.7%), MICROCHIP TECHNOLOGY INC. (7.4%), AABA (6.4%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q1 2019 Summary

Active quarter - 129 new positions, 0 exits, 0 increased. Top move: AABA (NEW, conviction 95). Portfolio: $4.4B across 134 positions.

Top holdings by portfolio weight

Total AUM$4B
MICROCHIP TE7.71%
MICROCHIP TE7.35%
AABA6.38%
TELADOC HEAL4.71%
HUAZHU GROUP4.16%
Apollo Comme3.47%
SAREPTA THER3.04%
EVERBRIDGE I2.99%
RINGCENTRAL 2.76%
OKTA INC2.68%
Other1.99%

Portfolio allocation by GICS sector

Sectors7
Unknown87.08%
Consumer Cyclical5.82%
Financial Services2.50%
Technology1.65%
Industrials1.55%
Real Estate1.19%
Healthcare0.21%

Behavioral investing profile

Checking access…
Momentum Trader
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record61
Conviction31
Concentration37
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
BR10806XAD4BRIDGEBIO PHARMA INC
Q3 2024 Q2 2026+157.4M shares+$200.5M
7Q
VI928298AR9VISHAY INTERTECHNOLOGY INC
Q4 2024 Q2 2026+353.9M shares+$770.5M
4Q
CO19459JAC8COLLEGIUM PHARMACEUTICAL INC
Q3 2025 Q2 2026+26.6M shares+$50.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used